مشروع البحث: The influence of Xelox and Folfox on colorectal cancer patients in Tripoli Medical Center Hospital’Tripoli
تحميل...
المساهمين
الممولين
رقم التعريف
2383
الباحث
فاطمة ابوالقاسم
الوصف
Abstract:
Colorectal cancer (CRC) ranks as the fourth most prevalent cancer
globally, accounting for 1.3 million new cases annually, with a 5-year
prevalence rate reaching 3.2 million.
Aims: The aim of this study is to evaluate and to provide data about the
treatment efficacy`s of two chemotherapies (including Folfox and Xelox)
that are frequently used in the oncology department of Tripoli University
Hospital (TUH) in Tripoli, Libya, to treat patients with colorectal cancer.
الكلمات الدالة
The influence of Xelox and Folfox on colorectal cancer patients in Tripoli Medical Center Hospital’Tripoli